The Open Arthritis Journal

2008, 1 : 1-7
Published online 2008 September 27. DOI: 10.2174/1876539400801010001
Publisher ID: TOARTHJ-1-1

RESEARCH ARTICLE
Intra-Articular Hyaluronan Treatment of Patients with Knee Osteoarthritis Waiting for Replacement Surgery

F.J. Blanco, * , J.L. Fernández-Sueiro, , J.A. Pinto-Tasende , J.C. Fernández-López , M. Ramallal , A. Freire and F. Galdo
Osteoarticular and Aging Research Unit, Rheumatology Division, INIBIC-Hospital Universitario A Coruña, Xubias 84, 15006-A Coruña, Spain

* Address correspondence to this author at the Laboratorio de Investigación Osteoarticular, Unidad de Investigación, Hospital Universitario A Coruña., C/ Xubias, 84, 15006-A Coruña, Spain; Tel: 34-981-178272; Fax: 34-981-178273; E-mail: fblagar@canalejo.org

ABSTRACT

Aim

To determine whether hyaluronan (HA) delays and/or reduces the knee replacement surgery (KRS) in patients with osteoarthritis (OA).

Material and Methods

A prospective, single-center, double-blind, randomized, placebo-controlled, pilot clinical trial with two treatment groups [HA (Adant®) treatment group and placebo treatment group] was conducted. The intra-articular treatments (HA or placebo) consisted of two cycles of five weekly injections with a 24-week interval between each cycle. The efficacy variable was determined by change in pain, articular mobility and functional capacity as measured by WOMAC. All efficacy variables have been analyzed for the intention-to-treat population.

Results

52 patients (10M/42F) were enrolled in the study (HA group: 26; placebo group: 26). Time until KRS in the HA group subjects (368.8 days) was longer than that in the placebo group (253.9 days). The change in the WOMAC stiffness subscale at 24 weeks, compared to the baseline score, was –22.4 in the HA group and -2.2 in the placebo group (p = 0.081). The change in the physical function WOMAC subscale, compared to the baseline score, was statistically significant at 24 weeks (HA group = -24.7 placebo group = -4.4 p = 0.019). Similar results were found in the change in the total WOMAC index score (HA group = -23.9 vs placebo group = -5.6 p = 0.044).

Conclusion

The use of intra-articular HA to treat OA patients on the waiting list for KRS does not delay surgery. However, it could improve the physical condition of patients while they are waiting by surgery.

Keywords:

Osteoarthritis, Hyaluronan, Treatment, Knee surgery.